Skip to search.
 TSX Down 0.69% TSX Ventures Down 0.10%

Agenus Inc. (AGEN)

-NasdaqCM
4.80 Down 0.08(1.64%) 10:05AM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:4.88
Open:4.85
Bid:4.83 x 1700
Ask:4.84 x 400
1y Target Est:9.25
Beta:1.05
Earnings Date:Mar 3 - Mar 9 (Est.)
Day's Range:4.76 - 4.93
52wk Range:2.27 - 6.49
Volume:102,102
Avg Vol (3m):2,197,410
Market Cap:300.88M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 1.64%300.88M
ABPI 0.00%N/A
DNDNDown 13.61%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):43.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.53
Quarterly EPS Est (Mar-15) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback